AN2 Total Liab from 2010 to 2024
| ANTX Stock | USD 1.99 0.04 1.97% |
Total Liabilities | First Reported 2010-12-31 | Previous Quarter 14 M | Current Value 13.3 M | Quarterly Volatility 28.7 M |
Check AN2 Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AN2 Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 73.1 M, Interest Expense of 620.7 K or Selling General Administrative of 7.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.68. AN2 financial statements analysis is a perfect complement when working with AN2 Therapeutics Valuation or Volatility modules.
AN2 | Total Liab |
Latest AN2 Therapeutics' Total Liab Growth Pattern
Below is the plot of the Total Liab of AN2 Therapeutics over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. AN2 Therapeutics' Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AN2 Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Total Liab | 10 Years Trend |
|
Total Liab |
| Timeline |
AN2 Total Liab Regression Statistics
| Arithmetic Mean | 12,048,123 | |
| Geometric Mean | 2,531,481 | |
| Coefficient Of Variation | 238.58 | |
| Mean Deviation | 15,529,514 | |
| Median | 887,000 | |
| Standard Deviation | 28,744,672 | |
| Sample Variance | 826.3T | |
| Range | 111.8M | |
| R-Value | 0.40 | |
| Mean Square Error | 749T | |
| R-Squared | 0.16 | |
| Significance | 0.14 | |
| Slope | 2,557,057 | |
| Total Sum of Squares | 11567.6T |
AN2 Total Liab History
About AN2 Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include AN2 Therapeutics income statement, its balance sheet, and the statement of cash flows. AN2 Therapeutics investors use historical funamental indicators, such as AN2 Therapeutics's Total Liab, to determine how well the company is positioned to perform in the future. Although AN2 Therapeutics investors may use each financial statement separately, they are all related. The changes in AN2 Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AN2 Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AN2 Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AN2 Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Liabilities | 14 M | 13.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for AN2 Stock Analysis
When running AN2 Therapeutics' price analysis, check to measure AN2 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AN2 Therapeutics is operating at the current time. Most of AN2 Therapeutics' value examination focuses on studying past and present price action to predict the probability of AN2 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AN2 Therapeutics' price. Additionally, you may evaluate how the addition of AN2 Therapeutics to your portfolios can decrease your overall portfolio volatility.